Mechanism of Serum PRL in the Development of MAFLD
NCT05525884
·
clinicaltrials.gov ↗
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Type2 Diabetes
Fatty Liver, Nonalcoholic
Liver Fibrosis
Interventions
OTHER:
non-invasive method, Fibroscan
Sponsor
Shen Qu